Patents by Inventor Liena QIN

Liena QIN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20260015349
    Abstract: Described herein are PHD inhibitors and pharmaceutical compositions comprising said inhibitors. The subject compounds and compositions are useful for the treatment of anemia.
    Type: Application
    Filed: October 28, 2022
    Publication date: January 15, 2026
    Inventors: Xiao DING, Liena QIN, Feng REN, Jianyu XU
  • Publication number: 20260007685
    Abstract: Provided herein are anti-apoptotic BCL-2 family protein degraders, e.g., a compound of Formula (I), and pharmaceutical compositions thereof. Also provided herein are methods of their use for treating, preventing, or ameliorating one or more symptoms of a disorder, disease, or condition mediated by an anti-apoptotic BCL-2 family protein.
    Type: Application
    Filed: July 14, 2023
    Publication date: January 8, 2026
    Inventors: Xiaorong Liu, Liang Zhao, Xiao Ding, Jinxin Liu, Hongfu Lu, Liena Qin, Feng Ren
  • Publication number: 20250214967
    Abstract: Provided herein are FAK degraders, e.g., a compound of Formula (I), and pharmaceutical compositions thereof. Also provided herein are methods of their use for treating, preventing, or ameliorating one or more symptoms of a disorder, disease, or condition mediated by an FAK.
    Type: Application
    Filed: March 29, 2023
    Publication date: July 3, 2025
    Inventors: Xiao Ding, Jinxin Liu, Liena Qin, Feng Ren
  • Publication number: 20250034132
    Abstract: Described herein are PHD inhibitors and pharmaceutical compositions comprising said inhibitors. The subject compounds and compositions are useful for the treatment of inflammatory bowel disease.
    Type: Application
    Filed: October 28, 2022
    Publication date: January 30, 2025
    Inventors: Xiao DING, Liena QIN, Feng REN, Jianyu XU
  • Patent number: 12209101
    Abstract: Described herein are PHD inhibitors and pharmaceutical compositions comprising said inhibitors. The subject compounds and compositions are useful for the treatment of anemia.
    Type: Grant
    Filed: August 31, 2023
    Date of Patent: January 28, 2025
    Assignee: INSILICO MEDICINE IP LIMITED
    Inventors: Xiao Ding, Liena Qin, Feng Ren, Jianyu Xu
  • Patent number: 12071443
    Abstract: Described herein are PHD inhibitors and pharmaceutical compositions comprising said inhibitors. The subject compounds and compositions are useful for the treatment of inflammatory bowel disease.
    Type: Grant
    Filed: June 22, 2023
    Date of Patent: August 27, 2024
    Assignee: INSILICO MEDICINE IP LIMITED
    Inventors: Xiao Ding, Liena Qin, Feng Ren, Jianyu Xu
  • Publication number: 20240067661
    Abstract: Described herein are PHD inhibitors and pharmaceutical compositions comprising said inhibitors. The subject compounds and compositions are useful for the treatment of anemia.
    Type: Application
    Filed: August 31, 2023
    Publication date: February 29, 2024
    Inventors: Xiao DING, Liena QIN, Feng REN, Jianyu XU
  • Publication number: 20240002406
    Abstract: Described herein are PHD inhibitors and pharmaceutical compositions comprising said inhibitors. The subject compounds and compositions are useful for the treatment of inflammatory bowel disease.
    Type: Application
    Filed: June 22, 2023
    Publication date: January 4, 2024
    Inventors: Xiao DING, Liena QIN, Feng REN, Jianyu XU
  • Patent number: 11780854
    Abstract: Described herein are PHD inhibitors and pharmaceutical compositions comprising said inhibitors. The subject compounds and compositions are useful for the treatment of anemia.
    Type: Grant
    Filed: February 15, 2023
    Date of Patent: October 10, 2023
    Assignee: Insilico Medicine IP Limited
    Inventors: Xiao Ding, Liena Qin, Feng Ren, Jianyu Xu
  • Patent number: 11731987
    Abstract: Described herein are PHD inhibitors and pharmaceutical compositions comprising said inhibitors. The subject compounds and compositions are useful for the treatment of inflammatory bowel disease.
    Type: Grant
    Filed: February 15, 2023
    Date of Patent: August 22, 2023
    Assignee: Insilico Medicine IP Limited
    Inventors: Xiao Ding, Liena Qin, Feng Ren, Jianyu Xu
  • Publication number: 20230192723
    Abstract: Described herein are PHD inhibitors and pharmaceutical compositions comprising said inhibitors. The subject compounds and compositions are useful for the treatment of anemia.
    Type: Application
    Filed: February 15, 2023
    Publication date: June 22, 2023
    Inventors: Xiao DING, Liena QIN, Feng REN, Jianyu XU
  • Publication number: 20230192688
    Abstract: Described herein are PHD inhibitors and pharmaceutical compositions comprising said inhibitors. The subject compounds and compositions are useful for the treatment of inflammatory bowel disease.
    Type: Application
    Filed: February 15, 2023
    Publication date: June 22, 2023
    Inventors: Xiao DING, Liena QIN, Feng REN, Jianyu XU